Filing Details

Accession Number:
0001445064-14-000079
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-18 17:57:14
Reporting Period:
2014-12-18
Filing Date:
2014-12-18
Accepted Time:
2014-12-18 17:57:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1567892 Mallinckrodt Plc MNK Pharmaceutical Preparations (2834) 981088325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1540412 Mark Trudeau 675 Mcdonnell Blvd.
Hazelwood MO 63042
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2014-12-18 19,438 $41.73 154,249 No 4 M Direct
Ordinary Shares Disposition 2014-12-18 7,900 $93.17 146,349 No 4 S Direct
Ordinary Shares Disposition 2014-12-18 5,931 $94.16 140,418 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Share Options (Right to Buy) Disposition 2014-12-18 19,438 $0.00 19,438 $41.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,875 2013-12-03 2022-12-02 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 4, 2014.
  2. This represents the weighted average price paid for the shares. The shares were purchased in multiple transactions at prices ranging from $93.03 to $94.01, inclusive. Mr. Trudeau will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
  3. This represents the weighted average price paid for the shares. The shares were purchased in multiple transactions at prices ranging from $94.03 to $94.50, inclusive. Mr. Trudeau will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.
  4. The options representing rights to purchase 77,750 ordinary shares became exercisable in four equal installments beginning December 3, 2013.